MIR7159

Across TCGA pan-cancer cohorts, MIR7159 RNA is linked to patient survival in 3 of 34 cancer types, making it the most broadly survival-associated MIR7159 data layer.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher MIR7159 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MIR7159 expression acts as an unfavorable survival marker.

LUAD, KIRC, and STAD are the cancer types where MIR7159 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	DFS	Tertile	All	0.178	0.813	<.001	63	view →
KIRC	OS	Tertile	II,III,IV	0.153	0.556	.008	36	view →
STAD	DFS	Tertile	All	0.284	0.564	.005	27	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

MIR7159–LUAD (DFS)

Open the LUAD breakdown →